Sitemap - September, 2005 - Medical Marketing and Media

Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Email*

Password*

Keep me logged in Forgot your password?

Email*

September, 2005:

Epstein out, Nosta in at Noesis

Lipitor cleared for reducing stroke risk in diabetics

Drug errors prompt pharma ‘dear doctor’ letters

Tysabri makers file sBLA

FDA names acting commissioner

Crawford resigns from FDA

Medicare approves prescription drug plans

Wyeth sees part-time reps offsetting full-time cuts

Vytorin sees growth without nibbling on Zetia

FDA to hold public meetings on DTC

DDMAC head says warnings tripled

Novartis re-launches patient education program

Retail drug prices up 25% over four years

Drug makers get double dose of bad news

Four in five docs support ad moratorium

AstraZeneca names Zook to head North America

GSK settles in fraud case

FDA names interim director to women's health post

Dendrite acquires Optas in $12 million deal

Novartis to file for new drugs, restates Chiron interest

Product news from 09/23 News Brief

Manufacturer news from 09/23 News Brief

Agency and supplier news from 09/23 News Brief

Company news from 09/23 News Brief

Lyrica launches with professional education push

Drug makers update effort to reinstate Tysabri

Test drugs against competitors, not placebos: New York Times editorial

Global pharma trade group launches clinical trials Web site

Lechleiter vaults to No. 2 position at Lilly

BMS merges U.S., global units; U.S. president departing

Generic does well against newer CNS drugs, gov’t. study finds

DDMAC head says warnings on ads have more than tripled in last year

Novartis to file for two new potential blockbusters, restates Chiron interest

FDA replaces Women’s Health director

Retail drug prices up 25 percent, government report finds

AstraZeneca names Tony Zook to lead North American operations

Novartis IT leader speaks on CRM success

Drug makers get dose of bad regulatory news

Wyeth to use seasoned part-timers to support reduced rep force

Novartis re-launches compliance program to fight high blood pressure

Dendrite acquires Optas in $12 million deal

FDA panel backs new diabetes drug

Counselor says Merck to play it straight in N.J.

Ventiv Health acquires InChord in $185 million deal

FDA review panels give nod to two drugs, votes on third today

Industry donates resources to Hurricane Katrina relief efforts

Pfizer no longer among nation’s top 10 advertisers

Statins cut risk of heart attack deaths: study

Chiron rejects $4.5 billion Novartis takeover bid

Sanofi-Aventis wins approval for new Ambien formulation

FDA official quits over Plan B decision

J&J asks doctors to limit Natrecor use

Biogen Idec to attempt Tysabri return

Merck may consider settling some Vioxx suits

Shire to resume marketing of Adderall XR

Product news from 09/09 News Brief

People News from 09/09 News Brief

Company news from 09/09 News Brief

Account wins from 09/09 News Brief

FDA postpones first stop on Crawford listening tour

Court dismisses lawsuit over drug imports

Novartis bids to buy U.S. vaccine maker Chiron

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma.